BK-VP3 as a new target of cellular immunity in BK virus infection

Transplantation

Volumn 91, Issue 1, 2011, Pages 100-107

  Mueller, Karin ^a   Schachtner, Thomas ^a   Sattler, Arne ^a   Meier, Sarah ^a   Friedrich, Peter ^a   Trydzenskaya, Hanna ^a   Hinrichs, Carl ^a   Trappe, Ralf ^a   Thiel, Andreas ^a   Reinke, Petra ^a   Babel, Nina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BKV associated nephropathy; Flow cytometry; Overlapping peptide pools; Polyomavirus BK

Indexed keywords

BK VP3 PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BK VIRUS; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG TARGETING; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGENICITY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REACTIVATION; VIRUS REPLICATION;

ADULT; AGED; ANTIGENS, VIRAL; BK VIRUS; CREATININE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR VIRUS INFECTIONS; VIRAL CORE PROTEINS;

EID: 78751647678     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fe1335     Document Type: Article

References (31)

1. Hirsch HH. Polyomavirus BK nephropathy: A (re-) emerging complication in renal transplantation. Am J Transplant 2002;2:25.
2. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007;2(suppl 1): S36.
3. Cai X, Chang D, Rottinghaus S, et al. Expression and purification of recombinant polyomavirus VP2 protein and its interactions with polyomavirus proteins. J Virol 1994;68:7609.
4. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003;3:611.
5. Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005;41:354.
6. Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007;7:1131.
7. + T-cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Hum Immunol 2006;67:298.
8. Hammer MH, Brestrich G, Andree H, et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant 2006;6:625.
9. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007;12:2727.
10. Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2009;13:569.
11. Hirsch HH. Virus infections post transplant: Risk and immunity. Transpl Infect Dis 2005;7:97.
12. Comoli P, Binggeli S, Ginevri F, et al. Polyomavirus-associated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 2006;8:86.
13. + T-cells with cytotoxic potential in seropositive adults. Viral Immunol 2007;20:379.
14. Randhawa P, Bohl D, Brennan D, et al. Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 2008;15:1564.
15. Kirchner A, Hoffmeister B, Cherepnev GG, et al. Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring. J Med Virol 2008;80:1604.
16. + T-cell responses during infectious mononucleosis. Clin Exp Immunol 2008;153:231.
17. MacLeod MK, McKee A, Crawford F, et al. CD4 memory T-cells divide poorly in response to antigen because of their cytokine profile. Proc Natl Acad Sci USA 2008;105:14521.
18. + memory T-cells in nonlymphoid tissues express a highly activated phenotype. J Immunol 2002;169:6655.
19. Swain SL, Hu H, Huston G. Class II-independent generation of CD4 memory T-cells from effectors. Science 1999;286:1381.
20. Comoli P, Schilham MW, Basso S, et al. T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipientcells can be obtained from HLA-haploidentical donors. J Immunother 2008;31:529.
21. Bunde T, Kirchner A, Hoffmeister B, et al. Protection from cytomegalovi-rus after transplantation is correlated with immediate early 1-specific CD8 T-cells. J Exp Med 2005;201:1031.
22. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333:1038.
23. Makedonas G, Betts MR. Polyfunctional analysis of human T-cell responses: Importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 2006;28:209.
24. Harari A, Vallelian F, Meylan PR, et al. Functional heterogeneity of memory CD4 T-cell responses in different conditions of antigen exposure and persistence. J Immunol 2005;174:1037.
25. Binggeli S, Egli A, Dickenmann M, et al. BKV replication and cellular immune responses in renal transplant recipients. Am J Transplant 2006;6:2218; author reply 2220.
26. + T-cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8:379.
27. Chen G, Shankar P, Lange C, et al. CD8 T-cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001;98:156.
28. Kern F, Faulhaber N, Frommel C, et al. Analysis of CD8 T-cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pen-tadecapeptides. Eur J Immunol 2000;30:1676.
29. Duvall MG, Precopio ML, Ambrozak DA, et al. Polyfunctional T-cell responses are a hallmark of HIV-2 infection. Eur J Immunol 2008;38:350.
30. Frentsch M, Arbach O, Kirchhoff D, et al. Direct access to CD4+ T-cells specific for defined antigens according to CD154 expression. Nat Med 2005;11:1118.
31. + T-cells. Cytometry 2008;73:1035.